Medical
After a limited launch, Microbot put Liberty on full sale in the US. Uses include treating fibroids, enlarged prostate and knee pain by blocking small arteries.
A dated step forward on the record · Company-reported
What the source says
“With the limited launch complete, the company can now proceed with the full release as planned, beginning at the Society of Interventional Radiology (SIR) Annual Scientific Meeting in Toronto this week.”
What it means
Liberty, from Microbot Medical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: Our sources report it working without human help.
